Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -336.81% is 167% below its 5-year average of -126.11%, near the low end of its 5-year range (-385.20%–54.35%).
6.09% below its 12-month average of -317.47%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -282.25%.
OPERATING MARGIN
-336.81%
OPERATING MARGIN AVG TTM
-317.47%
OPERATING MARGIN AVG 3Y
-203.71%
OPERATING MARGIN AVG 5Y
-126.11%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-6.09%
CURRENT VS 3Y AVG
-65.34%
CURRENT VS 5Y AVG
-167.08%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 554 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Gossamer Bio, Inc.
Market Cap
$65.99M
Operating Margin
-336.81%
TTM Avg
-317.47%
3Y Avg
-203.71%
5Y Avg
-126.11%
Market Cap
$64.06M
Operating Margin
-69.62%
TTM Avg
-71.11%
3Y Avg
-78.39%
5Y Avg
-54.75%
Market Cap
$68.10M
Operating Margin
-111.00%
TTM Avg
-151.19%
3Y Avg
-184.89%
5Y Avg
-203.40%
Market Cap
$63.14M
Operating Margin
2.49%
TTM Avg
-12.82%
3Y Avg
-6.08%
5Y Avg
-11.76%
Market Cap
$62.97M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$69.33M
Operating Margin
-1.72%
TTM Avg
3.29%
3Y Avg
-3.87%
5Y Avg
-2.22%
Market Cap
$69.77M
Operating Margin
-7.19%
TTM Avg
-4.82%
3Y Avg
-64.73%
5Y Avg
-128.10%
Market Cap
$70.86M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | $65.99M | -336.81% | -317.47% | -203.71% | -126.11% |
| Cingulate Inc. (CING)vs › | $65.53M | 0.00% | 0.00% | 0.00% | 0.00% |
| Alps Group Inc (ALPS)vs › | $64.06M | -69.62% | -71.11% | -78.39% | -54.75% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.10M | -111.00% | -151.19% | -184.89% | -203.40% |
| InterCure Ltd. (INCR)vs › | $63.14M | 2.49% | -12.82% | -6.08% | -11.76% |
| Kalaris Therapeutics Inc (KLRS)vs › | $62.97M | 0.00% | 0.00% | 0.00% | 0.00% |
| Champions Oncology, Inc. (CSBR)vs › | $69.33M | -1.72% | 3.29% | -3.87% | -2.22% |
| Heron Therapeutics, Inc. (HRTX)vs › | $69.77M | -7.19% | -4.82% | -64.73% | -128.10% |
| PDS Biotechnology Corporation (PDSB)vs › | $70.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| iBio, Inc. (IBIO)vs › | $70.09M | -35141.00% | -19895.75% | -11796.10% | -8345.47% |
Gross Margin
99.6%
Operating Margin
-336.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -282.25% |
| 2026-03-31 | -264.62% |
| 2025-12-31 | -333.65% |
| 2025-09-30 | -369.44% |
| 2025-06-30 | -337.41% |
| 2025-03-31 | -372.23% |
| 2024-12-31 | -385.20% |
| 2024-09-30 | -357.80% |
| 2024-06-30 | 54.35% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
